Cargando…

Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19

Detalles Bibliográficos
Autores principales:	Davis, Corey S., Samuels, Elizabeth A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428767/ https://www.ncbi.nlm.nih.gov/pubmed/32811685 http://dx.doi.org/10.1016/j.drugpo.2020.102905

Ejemplares similares

Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic
por: Wang, Linda, et al.
Publicado: (2021)

Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island
por: Clark, Seth A., et al.
Publicado: (2021)

Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period
por: Lembke, Anna, et al.
Publicado: (2019)

Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs
por: Lambdin, Barrot H., et al.
Publicado: (2022)

Low-Threshold Buprenorphine via Community Partnerships and Telemedicine—Case Reports of Expanding Access to Addiction Treatment During COVID-19
por: Levander, Ximena A., et al.
Publicado: (2022)

Improving obesity treatment through telemedicine: increasing access to bariatric surgery
por: Chao, Grace F., et al.
Publicado: (2021)

The pressing shortage of buprenorphine prescribers and the pending role of telemedicine
por: Molfenter, Todd
Publicado: (2015)

Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic
por: Mattocks, Kristin M., et al.
Publicado: (2022)

Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder
por: Weintraub, Eric, et al.
Publicado: (2021)

Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage
por: Barsky, Benjamin A., et al.
Publicado: (2022)

Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19
por: Samuels, Elizabeth A., et al.
Publicado: (2022)

Telemedicine for COVID-19()
por: Ena, J.
Publicado: (2020)

Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees
por: Hammerslag, Lindsey R., et al.
Publicado: (2023)

Utilizing telemedicine during COVID-19 pandemic for a low-threshold, street-based buprenorphine program
por: Harris, Robert, et al.
Publicado: (2022)

Telemedicine in the Wake of the COVID-19 Pandemic: Increasing Access to Surgical Care
por: Dekker, Paige K., et al.
Publicado: (2020)

More room for telemedicine after COVID-19: lessons for primary care?
por: Garattini, Livio, et al.
Publicado: (2020)

Patient and Clinician Characteristics Associated with Use of Telemedicine for Buprenorphine Induction Among Medicare Beneficiaries
por: Patel, Sadiq Y., et al.
Publicado: (2022)

Suicide rates in the United States continue to rise. Are rates in Brazil underestimated?
por: Scaini, Giselli, et al.
Publicado: (2018)

Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment
por: Stein, Bradley D., et al.
Publicado: (2023)

Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018
por: Conway, Kevin P., et al.
Publicado: (2022)

Improving Uptake of Emergency Department-initiated Buprenorphine: Barriers and Solutions
por: Kelly, Timothy D., et al.
Publicado: (2022)

Access to and Payment for Office-Based Buprenorphine Treatment in Ohio
por: Parran, Theodore V, et al.
Publicado: (2017)

Continuing Peanut Oral Immunotherapy via Telemedicine During the COVID-19 Pandemic
por: Schoonover, Anna, et al.
Publicado: (2021)

Telemedicine in the United States: An Introduction for Students and Residents
por: Hyder, Maryam A, et al.
Publicado: (2020)

A Telemedicine Buprenorphine Clinic to Serve New York City: Initial Evaluation of the NYC Public Hospital System's Initiative to Expand Treatment Access During the COVID-19 Pandemic
por: Tofighi, Babak, et al.
Publicado: (2022)

Low-barrier buprenorphine during the COVID-19 pandemic: A rapid transition to on-demand telemedicine with wide-ranging effects
por: Buchheit, Bradley M., et al.
Publicado: (2021)

COVID Will End But Telemedicine May be Here to Stay
por: Krueger, C.A., et al.
Publicado: (2021)

The impact of COVID-19 on the development and consolidation of telemedicine
por: Mariani, Alessandro Wasum, et al.
Publicado: (2021)

Impact of telemedicine on access to acute stroke care in the state of Texas
por: Wu, Tzu-Ching, et al.
Publicado: (2014)

Impact of telemedicine on access to acute stroke care in the state of Texas
por: Wu, Tzu-Ching, et al.
Publicado: (2014)

Emergency Department Visits and Hospitalizations for Buprenorphine Ingestion by Children — United States, 2010–2011
por: Lovegrove, Maribeth, et al.
Publicado: (2013)

An analysis of patterns of distribution of buprenorphine in the United States using ARCOS, Medicaid, and Medicare databases
por: Hsu, Zhi‐Shan, et al.
Publicado: (2023)

Telemedicine and rheumatology
por: Nash, Peter
Publicado: (2022)

Continuing Medical Education via Telemedicine and Sustainable Improvements to Health
por: Wang, Fuhmei
Publicado: (2016)

Implications of Increased Access to Buprenorphine for Medical Providers in Rural Areas: A Review of the Literature and Future Directions
por: Gregory, Hannah M, et al.
Publicado: (2021)

Nothing really changed: Arizona patient experience of methadone and buprenorphine access during COVID
por: Meyerson, Beth E., et al.
Publicado: (2022)

Postoperative respiratory depression in patients on sublingual buprenorphine: a retrospective cohort study for comparison between postoperative continuation and discontinuation of buprenorphine
por: Komatsu, Ryu, et al.
Publicado: (2022)

Telemedicine, legal certainty, and COVID-19: where are we?
por: Garcia, Marcos Vinicius Fernandes, et al.
Publicado: (2020)

Use of telemedicine to combat the COVID-19 pandemic in Brazil
por: Carvalho, Carlos Roberto Ribeiro, et al.
Publicado: (2020)

Telemedicine in the COVID-19 era: a tricky transition
por: Palabindala, Venkataraman, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0jc6ehcdjulukik50atvievaed